🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes - thanks to the international community that helped forge this. onlinelibrary.wiley.com/doi/10.1111/pe…

2022 ISPAD glycemic targets. This figure was designed as an education aid in clinic. I hope it is helpful

#DiabeticKetoacidosis (DKA) can be present the first time a child presents with diabetes and can have clinically serious consequences. This systemic review identified and categorized risk factors for children with new onset #diabetes in DKA. ja.ma/3F2jspm

Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes ja.ma/3XX69xV via JAMA part of JAMA Network

Diabetic Kidney Disease is a major problem for people with diabetes. It’s important we understand what drives kidney disease, so we develop therapeutic targets to stop progression and improve mortality and quality of life in patients. #worldkidneyday #kidneyresearch #cardiorenal

"We are excited about being part of the CTS INNODIA Network and looking forward to participating in new trials aimed at preventing and curing Type 1 diabetes".

15-minute consultation Management of albuminuria in children and young people with diabetes IsabellaWeber, Loredana Marcovecchio ep.bmj.com/content/early/…

Thanks to Diabetes UK for supporting this work and UK clinicians and researchers coming together to support this much needed registry Partha S Kar 🇮🇳🇬🇧🏏🎥 justin webb bbc.co.uk/news/uk-englan…

very pleased to be part of this great project! University of Cambridge Department of Paediatrics 'bbc.co.uk/news/uk-englan…

The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults. link.springer.com/article/10.100… INNODIA University of Cambridge Department of Paediatrics

Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes - Hendriks - 2024 - Diabetes/Metabolism Research and Reviews - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/dm… INNODIA University of Cambridge Department of Paediatrics

The INNODIA cohort study of children, adolescents and adults with newly diagnosed type 1 diabetes identified key age-related differences in clinical variables, beta cell function, glucose metrics & autoimmune characteristics INNODIA #T1D #Diabetes tinyurl.com/56na8az3 🔓

Do you see them? These are the experts INNODIA promised - back in 2015 - to bring together in one consortium with only one goal: To fight #type1diabetes. Anyone can see that INNODIA's communitiy has become a true family. The collaborative spirit is even palpable in the picture!

The INNODIA non-profit organization composes the expertteam you need. The more specific your questions are, the better expertise we can provide. Sharp questions will be answered by clear answers! Reach out! innodia.org

The first ever medical code for presymptomatic #Type1Diabetes launches today, which will give people in the earliest stages of #T1D access to better support, healthcare, education and emerging treatments for type 1. 📰 Learn more: jdrf.org.uk/news/new-inter… #GBDoc SNOMED International

Results from the multicentre INNODIA T1D study: Faecal Feacalibacterium prausnitzii abundance inversely correlated with HbA1c levels at diagnosis in newly diagnosed individuals. Tommi Vatanen INNODIA University of Helsinki Medicine and Health, University of Helsinki HiLIFE_Helsinki tinyurl.com/3mxtyyh6 🔓

📢 Check out the international consensus guidance for monitoring autoantibody-positive individuals in early-stage type 1 diabetes. FREE to Read 🔗 diabetesjournals.org/care/lookup/do… ADA Professional Publications American Diabetes Association American Diabetes Association - DiabetesPro Diabetologia Moshe Phillip

🧵 To treat or not to treat micro/macrovascular complications in youth: benefits and drawback -M. Loredana Marcovecchio Cumulative risk factors, modifiable or not: 👉 Genetic 👉 Gender 👉 Ethnicity 👉 Puberty/hormonal changes #ISPAD2024 #dedoc° ISPAD #dedoc° #PwD

🧵 #T1D screening... and now what? New guidelines for post-screening monitoring -M Loredana Marcovecchio ✅ Benefits of screening: Delay progression towards stage 3 ⬆️ Population screening: ⬆️ AAB+ 🧑‍🤝‍🧑 Education & psychological support #ISPAD2024 #dedoc° ISPAD #dedoc°

When asked to draw a scientist, school-age kids in the United States are increasingly sketching women, according to a study from 2018. Read more on #STEMSTEAMDay: bit.ly/3CghCUd